ATC code R03
Pharmaceutical drug classification
- 3 min read
- 4 chapters
Related on Lably
Through Medication
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QR03. ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
R03A Adrenergics, inhalants
R03AA Alpha- and beta-adrenoreceptor agonists
- R03AA01 Epinephrine
R03AB Non-selective beta-adrenoreceptor agonists
- R03AB02 Isoprenaline
- R03AB03 Orciprenaline
R03AC Selective beta-2-adrenoreceptor agonists
- R03AC02 Salbutamol
- R03AC03 Terbutaline
- R03AC04 Fenoterol
- R03AC05 Rimiterol
- R03AC06 Hexoprenaline
- R03AC07 Isoetarine
- R03AC08 Pirbuterol
- R03AC09 Tretoquinol
- R03AC10 Carbuterol
- R03AC11 Tulobuterol
- R03AC12 Salmeterol
- R03AC13 Formoterol
- R03AC14 Clenbuterol
- R03AC15 Reproterol
- R03AC16 Procaterol
- R03AC17 Bitolterol
- R03AC18 Indacaterol
- R03AC19 Olodaterol
R03AH Combinations of adrenergics
R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
- R03AK01 Epinephrine and other drugs for obstructive airway diseases
- R03AK02 Isoprenaline and other drugs for obstructive airway diseases
- R03AK04 Salbutamol and sodium cromoglicate
- R03AK05 Reproterol and sodium cromoglicate
- R03AK06 Salmeterol and fluticasone
- R03AK07 Budesonide and formoterol
- R03AK08 Formoterol and beclometasone
- R03AK09 Formoterol and mometasone
- R03AK10 Vilanterol and fluticasone furoate
- R03AK11 Formoterol and fluticasone
- R03AK12 Salmeterol and budesonide
- R03AK13 Salbutamol and beclometasone
- R03AK14 Indacaterol and mometasone
- R03AK15 Salbutamol and budesonide
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
- R03AL01 Fenoterol and ipratropium bromide
- R03AL02 Salbutamol and ipratropium bromide
- R03AL03 Vilanterol and umeclidinium bromide
- R03AL04 Indacaterol and glycopyrronium bromide
- R03AL05 Formoterol and aclidinium bromide
- R03AL06 Olodaterol and tiotropium bromide
- R03AL07 Formoterol and glycopyrronium bromide
- R03AL08 Vilanterol, umeclidinium bromide, and fluticasone furoate
- R03AL09 Formoterol, glycopyrronium bromide and beclometasone
- R03AL10 Formoterol and tiotropium bromide
- R03AL11 Formoterol, glycopyrronium bromide, and budesonide
- R03AL12 Indacaterol, glycopyrronium bromide and mometasone
Sign in to keep reading
3 more chapters are free with a Lably account.
R03B Other drugs for obstructive airway diseases, inhalants
R03BA Glucocorticoids
- R03BA01 Beclometasone
- R03BA02 Budesonide
- R03BA03 Flunisolide
- R03BA04 Betamethasone
- R03BA05 Fluticasone
- R03BA06 Triamcinolone
- R03BA07 Mometasone
- R03BA08 Ciclesonide
- R03BA09 Fluticasone furoate
R03BB Anticholinergics
- R03BB01 Ipratropium bromide
- R03BB02 Oxitropium bromide
- R03BB03 Stramoni preparations
- R03BB04 Tiotropium bromide
- R03BB05 Aclidinium bromide
- R03BB06 Glycopyrronium bromide
- R03BB07 Umeclidinium bromide
- R03BB08 Revefenacin
- R03BB54 Tiotropium bromide, combinations
R03BC Antiallergic agents, excluding corticosteroids
- R03BC01 Cromoglicic acid
- R03BC03 Nedocromil
R03BX Other drugs for obstructive airway diseases, inhalants
- R03BX01 Fenspiride
- R03BX02 Ensifentrine
R03C Adrenergics for systemic use
R03CA Alpha- and beta-adrenoreceptor agonists
- R03CA02 Ephedrine
R03CB Non-selective beta-adrenoreceptor agonists
- R03CB01 Isoprenaline
- R03CB02 Methoxyphenamine
- R03CB03 Orciprenaline
- R03CB51 Isoprenaline, combinations
- R03CB53 Orciprenaline, combinations
R03CC Selective beta-2-adrenoreceptor agonists
- R03CC02 Salbutamol
- R03CC03 Terbutaline
- R03CC04 Fenoterol
- R03CC05 Hexoprenaline
- R03CC06 Isoetarine
- R03CC07 Pirbuterol
- R03CC08 Procaterol
- R03CC09 Tretoquinol
- R03CC10 Carbuterol
- R03CC11 Tulobuterol
- R03CC12 Bambuterol
- R03CC13 Clenbuterol
- R03CC14 Reproterol
- R03CC15 Formoterol
- R03CC53 Terbutaline, combinations
- R03CC63 Clenbuterol and ambroxol
- QR03CC90 Clenbuterol, combinations
R03CK Adrenergics and other drugs for obstructive airway diseases
R03D Other systemic drugs for obstructive airway diseases
R03DA Xanthines
- R03DA01 Diprophylline
- R03DA02 Choline theophyllinate
- R03DA03 Proxyphylline
- R03DA04 Theophylline
- R03DA05 Aminophylline
- R03DA06 Etamiphylline
- R03DA07 Theobromine
- R03DA08 Bamifylline
- R03DA09 Acefylline piperazine
- R03DA10 Bufylline
- R03DA11 Doxofylline
- R03DA12 Mepyramine theophyllinacetate
- R03DA20 Combinations of xanthines
- R03DA51 Diprophylline, combinations
- R03DA54 Theophylline, combinations excluding psycholeptics
- R03DA55 Aminophylline, combinations
- R03DA57 Theobromine, combinations
- R03DA74 Theophylline, combinations with psycholeptics
R03DB Xanthines and adrenergics
- R03DB01 Diprophylline and adrenergics
- R03DB02 Choline theophyllinate and adrenergics
- R03DB03 Proxyphylline and adrenergics
- R03DB04 Theophylline and adrenergics
- R03DB05 Aminophylline and adrenergics
- R03DB06 Etamiphylline and adrenergics
R03DC Leukotriene receptor antagonists
- R03DC01 Zafirlukast
- R03DC02 Pranlukast
- R03DC03 Montelukast
- R03DC04 Ibudilast
- R03DC53 Montelukast, combinations
R03DX Other systemic drugs for obstructive airway diseases
- R03DX01 Amlexanox
- R03DX02 Eprozinol
- R03DX03 Fenspiride
- R03DX05 Omalizumab
- R03DX06 Seratrodast
- R03DX07 Roflumilast
- R03DX08 Reslizumab
- R03DX09 Mepolizumab
- R03DX10 Benralizumab
- R03DX11 Tezepelumab
- R03DX12 Depemokimab
More in Health
Food and Drug AdministrationFederal agency of the United States Department of Health and Human ServicesCenters for Disease Control and PreventionUnited States government public health agencyNauseaMedical symptom or conditionSeizurePeriod of symptoms due to excessive or synchronous neuronal brain activityVomitingExpulsion of stomach contents via the mouth or noseIntravenous therapyMedication administered into a vein